NCT06737731 2026-01-09A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid TumorsSuzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 1/2 Recruiting300 enrolled